Stockreport

Aimmune's PDUFA Jitters, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]

AIMMUNE THERAPEUTICS  (AIMT) 
Last aimmune therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aimmune.com/corporate-profile
PDF Summary Palforzia PDUFA has not yet been announced by the FDA. Amarin gets Canadian approval. EyeGate crashed on offering. Aimmune Therapeutics, Inc. (NASDAQ: AIMT appro [Read more]